What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Diabetes mellitus
- Gene
His primary scientific interests are in Internal medicine, Endocrinology, Type 2 diabetes, Obesity and Weight loss.
His Internal medicine research incorporates elements of Diabetes mellitus, Placebo and Surgery.
His Endocrinology research incorporates themes from Liver biopsy and Fatty liver.
The study incorporates disciplines such as Metformin, Inflammation and Gerontology in addition to Type 2 diabetes.
The Obesity study combines topics in areas such as Anthropometry, Healthy control and Disease.
His work in the fields of Weight management and Orlistat overlaps with other areas such as Rimonabant.
His most cited work include:
- Mechanisms linking obesity with cardiovascular disease (1966 citations)
- Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study (1368 citations)
- Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study (745 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Internal medicine, Endocrinology, Obesity, Diabetes mellitus and Type 2 diabetes.
His research investigates the connection between Internal medicine and topics such as Gastroenterology that intersect with problems in Fibrosis.
In his study, Liver biopsy and Steatosis is strongly linked to Fatty liver, which falls under the umbrella field of Endocrinology.
His Obesity study combines topics from a wide range of disciplines, such as Genetics, Anthropometry, Single-nucleotide polymorphism and Disease.
His Diabetes mellitus research is multidisciplinary, incorporating perspectives in Surgery and Intensive care medicine.
His study looks at the intersection of Weight loss and topics like Placebo with Randomized controlled trial.
He most often published in these fields:
- Internal medicine (69.96%)
- Endocrinology (45.79%)
- Obesity (31.87%)
What were the highlights of his more recent work (between 2016-2021)?
- Internal medicine (69.96%)
- Diabetes mellitus (27.47%)
- Gastroenterology (12.45%)
In recent papers he was focusing on the following fields of study:
Luc Van Gaal spends much of his time researching Internal medicine, Diabetes mellitus, Gastroenterology, Obesity and Type 2 diabetes.
Luc Van Gaal has included themes like Placebo, Endocrinology and Prediabetes in his Internal medicine study.
His Endocrinology study integrates concerns from other disciplines, such as Genetics and Gene.
His Diabetes mellitus study deals with Disease intersecting with Side effect, Psychopathology, Visceral fat and Artery.
His Overweight study in the realm of Obesity connects with subjects such as Opioid antagonist.
His Type 2 diabetes study combines topics in areas such as Weight gain and Physiology.
Between 2016 and 2021, his most popular works were:
- Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial (555 citations)
- 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial (237 citations)
- Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis (197 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Diabetes mellitus
- Gene
Luc Van Gaal mainly investigates Internal medicine, Type 2 diabetes, Placebo, Diabetes mellitus and Gastroenterology.
His Internal medicine study frequently links to adjacent areas such as Endocrinology.
The various areas that Luc Van Gaal examines in his Type 2 diabetes study include Adiponectin, Clinical trial and Adipokine.
His work deals with themes such as Randomized controlled trial, Semaglutide and Weight management, which intersect with Placebo.
His studies deal with areas such as Proportional hazards model and Genotype as well as Diabetes mellitus.
His work focuses on many connections between Gastroenterology and other disciplines, such as Fibrosis, that overlap with his field of interest in Extracellular matrix, Nonalcoholic fatty liver disease and Dermatopontin.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
